| Pharmaceutical active ingredients: |
| Dihydroergotamine MesylateEtilefrine Hydrochloride |
| Available forms, composition and doses of Ergolefrin: |
| Tablets, Retard; Oral; Dihydroergotamine Mesylate; Etilefrine Hydrochloride |
| Ergolefrin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA51 - Dihydroergotamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Gepepharm |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Agit Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Sanol |
| Dihydergot Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Novartis |
| Effortil Comp | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Boehringer Ingelheim |
| Effortil Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Boehringer Ingelheim |
| Effortil Plus Perlongetten | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Boehringer Ingelheim |
| Ergomimet Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Fujisawa |
| Hypodyn | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Novartis |
| Embolex | Dihydroergotamine Mesylate; Heparin Sodium; Lidocaine Hydrochloride | Novartis |
| Orstanorm med Heparin | Dihydroergotamine Mesylate; Heparin Sodium; Lidocaine Hydrochloride | Novartis; Sandoz |
| Optalidon Special NOC | Dihydroergotamine Mesylate; Propyphenazone | Novartis |